Retatrutide is a new, powerful weight loss medication that is generating significant interest
As a relatively new category of medicine, these drugssuch as Ozempic, Wegovy, Mounjaro and morehave been the subject of considerable attention for helping people with obesity lose up to 15 percent of their body weight in a relatively short period of time
This selective action has made it a significant area of research for metabolic disorders, particularly those related to obesity and fat metabolism, without the broader endocrine impacts associated with intact growth hormone
In general, adults may be candidates for GLP-1 medications if they: Have a BMI of 30 or higher or
Find Out More Store in a cool dry place, in original packaging, out of sight and reach of young children
Discontinue use and consult your doctor if any adverse reactions occur